{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:28:45Z","timestamp":1786987725339,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1163961"],"award-info":[{"award-number":["1163961"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1189975"],"award-info":[{"award-number":["1189975"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.drugpo.2022.103856","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T19:52:04Z","timestamp":1663703524000},"page":"103856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["How do patient, pharmacist and medication characteristics and prescription drug monitoring program alerts influence pharmacists' decisions to dispense opioids? A randomised controlled factorial experiment"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-3209","authenticated-orcid":false,"given":"Louisa","family":"Picco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-1055","authenticated-orcid":false,"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drugpo.2022.103856_bib0001","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/08964289.2018.1555129","article-title":"Substance use stigma, primary care, and the New York state prescription drug monitoring program","volume":"46","author":"Allen","year":"2020","journal-title":"Behavioral Medicine"},{"key":"10.1016\/j.drugpo.2022.103856_bib0002","series-title":"Factorial survey experiments","author":"Auspurg","year":"2015"},{"key":"10.1016\/j.drugpo.2022.103856_bib0003","series-title":"National, state and territory population canberra","year":"2020"},{"issue":"10","key":"10.1016\/j.drugpo.2022.103856_bib0004","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1513\/AnnalsATS.201901-024OC","article-title":"Association of opioid and benzodiazepine use with adverse respiratory events in older adults with chronic obstructive pulmonary disease","volume":"16","author":"Baillargeon","year":"2019","journal-title":"Annals of the American Thoracic Society"},{"key":"10.1016\/j.drugpo.2022.103856_bib0005","series-title":"Prescription monitoring: Keeping watch","first-page":"28","author":"Barbeler","year":"2018"},{"issue":"4","key":"10.1016\/j.drugpo.2022.103856_bib0006","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S2215-0366(19)30041-0","article-title":"Automation to optimise physician treatment of individual patients: Examples in psychiatry","volume":"6","author":"Bauer","year":"2019","journal-title":"The Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.drugpo.2022.103856_bib0007","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1176\/appi.ajp.2015.15020262","article-title":"Prescription opioid misuse, abuse, and treatment in the United States: An update","volume":"173","author":"Brady","year":"2016","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.drugpo.2022.103856_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100592","article-title":"Risk factors for indicators of opioid-related harms among people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study","volume":"28","author":"Campbell","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.drugpo.2022.103856_bib0009","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jamia\/ocx066","article-title":"Automatable algorithms to identify nonmedical opioid use using electronic data: A systematic review","volume":"24","author":"Canan","year":"2017","journal-title":"Journal of the American Medical Informatics Association"},{"key":"10.1016\/j.drugpo.2022.103856_bib0010","first-page":"1","article-title":"Risk of overdose with exposure to prescription opioids, benzodiazepines, and non-benzodiazepine sedative-hypnotics in adults: A retrospective cohort study","author":"Cho","year":"2020","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.drugpo.2022.103856_bib0011","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"11","key":"10.1016\/j.drugpo.2022.103856_bib0013","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.2105\/AJPH.2015.302856","article-title":"Overdose epidemic, prescription monitoring programs, and public health: A review of state laws","volume":"105","author":"Davis","year":"2015","journal-title":"American Journal of Public Health"},{"issue":"10208","key":"10.1016\/j.drugpo.2022.103856_bib0014","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: Harms to populations, interventions, and future action","volume":"394","author":"Degenhardt","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2022.103856_bib0015","series-title":"Regulatory Impact Statement \u2013 Proposed Drugs, Poisons and Controlled Substances Amendment (Real-time prescription monitoring) regulations 2018","year":"2018"},{"key":"10.1016\/j.drugpo.2022.103856_bib0017","series-title":"Modified monash model","year":"2019"},{"key":"10.1016\/j.drugpo.2022.103856_bib0064","series-title":"SafeScript: Frequently asked questions \u2013 for health professionals Melbourne:","year":"2020"},{"key":"10.1016\/j.drugpo.2022.103856_bib0016","series-title":"SafeScript: For prescribers and pharmacists Melbourne","year":"2021"},{"key":"10.1016\/j.drugpo.2022.103856_bib0018","series-title":"National real time prescription monitoring (RTPM) Canberra","year":"2022"},{"issue":"15","key":"10.1016\/j.drugpo.2022.103856_bib0019","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drugpo.2022.103856_bib0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1748-5908-1-28","article-title":"Do self- reported intentions predict clinicians' behaviour: A systematic review","volume":"1","author":"Eccles","year":"2006","journal-title":"Implementation Science : IS"},{"issue":"3","key":"10.1016\/j.drugpo.2022.103856_bib0021","article-title":"Methods to increase response to postal and electronic questionnaires","author":"Edwards","year":"2009","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.drugpo.2022.103856_bib0022","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5811\/westjem.2017.12.35957","article-title":"Optimal implementation of prescription drug monitoring programs in the emergency department","volume":"19","author":"Elder","year":"2018","journal-title":"Western Journal of Emergency Medicine"},{"issue":"11","key":"10.1016\/j.drugpo.2022.103856_bib0023","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/M17-3074","article-title":"Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses: A systematic review","volume":"168","author":"Fink","year":"2018","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1016\/j.drugpo.2022.103856_bib0024","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jamia\/ocx075","article-title":"Implementing prescription drug monitoring and other clinical decision support for opioid risk mitigation in a military health care setting: A qualitative feasibility study","volume":"25","author":"Finley","year":"2018","journal-title":"Journal of the American Medical Informatics Association : JAMIA"},{"issue":"3","key":"10.1016\/j.drugpo.2022.103856_bib0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1331\/JAPhA.2014.13168","article-title":"Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions","volume":"54","author":"Fleming","year":"2003","journal-title":"Journal of the American Pharmaceutical Association"},{"key":"10.1016\/j.drugpo.2022.103856_bib0026","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.drugpo.2017.02.005","article-title":"Addiction stigma and the biopolitics of liberal modernity: A qualitative analysis","volume":"44","author":"Fraser","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2022.103856_bib0027","first-page":"10","article-title":"Drug diverting patients & prescription monitoring\u2013both sides of the debate","volume":"94","author":"Freeman","year":"2004","journal-title":"Iowa Medicine\u202f: Journal of the Iowa Medical Society"},{"issue":"6","key":"10.1016\/j.drugpo.2022.103856_bib0028","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.sapharm.2018.09.007","article-title":"Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study","volume":"15","author":"Freeman","year":"2019","journal-title":"Research in Social and Administrative Pharmacy"},{"issue":"7","key":"10.1016\/j.drugpo.2022.103856_bib0029","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MLR.0000000000000738","article-title":"Patterns of opioid use and risk of opioid overdose death among medicaid patients","volume":"55","author":"Garg","year":"2017","journal-title":"Medical Care"},{"issue":"1","key":"10.1016\/j.drugpo.2022.103856_bib0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/j.pain.0000000000001078","article-title":"High-risk prescribing and opioid overdose: Prospects for prescription drug monitoring program-based proactive alerts","volume":"159","author":"Geissert","year":"2018","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.drugpo.2022.103856_bib0031","doi-asserted-by":"crossref","first-page":"e24268","DOI":"10.1097\/MD.0000000000024268","article-title":"Obstetrician-gynecologist perceptions and utilization of prescription drug monitoring programs: A survey study","volume":"100","author":"Goodin","year":"2021","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.drugpo.2022.103856_bib0032","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1331\/JAPhA.2013.12094","article-title":"How does use of a prescription monitoring program change pharmacy practice?","volume":"53","author":"Green","year":"2013","journal-title":"Journal of the American Pharmacists Association"},{"issue":"1","key":"10.1016\/j.drugpo.2022.103856_bib0033","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/08897077.2017.1365803","article-title":"Interprofessional prescription opioid abuse communication among prescribers and pharmacists: A qualitative analysis","volume":"39","author":"Hagemeier","year":"2018","journal-title":"Substance Abuse"},{"issue":"10","key":"10.1016\/j.drugpo.2022.103856_bib0034","first-page":"S200","article-title":"Introduction to the opioid epidemic: The economic burden on the healthcare system and impact on quality of life","volume":"24","author":"Hagemeier","year":"2018","journal-title":"The American Journal of Managed Care"},{"key":"10.1016\/j.drugpo.2022.103856_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103549","article-title":"Key considerations for the implementation of clinically focused prescription drug monitoring programs to avoid unintended consequences","volume":"101","author":"Haines","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2022.103856_bib0036","unstructured":"NSW Health (2021).Frequently asked questions - supply of medicines: NSW Goverment; [Available from: Https:\/\/www.health.nsw.gov.au\/pharmaceutical\/pharmacists\/Pages\/faq-supply-of-medicines.aspx."},{"issue":"7","key":"10.1016\/j.drugpo.2022.103856_bib0037","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/pme.12469","article-title":"How clinicians use prescription drug monitoring programs: A qualitative inquiry","volume":"15","author":"Hildebran","year":"2014","journal-title":"Pain Medicine"},{"issue":"11","key":"10.1016\/j.drugpo.2022.103856_bib0038","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/pm\/pnw019","article-title":"Clinical styles and practice policies: Influence on communication with patients regarding worrisome prescription drug monitoring program data","volume":"17","author":"Hildebran","year":"2016","journal-title":"Pain Medicine"},{"issue":"8","key":"10.1016\/j.drugpo.2022.103856_bib0039","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2105\/AJPH.2020.305696","article-title":"A history of prescription drug monitoring programs in the United States: Political appeal and public health efficacy","volume":"110","author":"Holmgren","year":"2020","journal-title":"American Journal of Public Health"},{"issue":"10","key":"10.1016\/j.drugpo.2022.103856_bib0040","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/jamia\/ocz095","article-title":"Medication safety alert fatigue may be reduced via interaction design and clinical role tailoring: A systematic review","volume":"26","author":"Hussain","year":"2019","journal-title":"Journal of the American Medical Informatics Association"},{"issue":"7","key":"10.1016\/j.drugpo.2022.103856_bib0041","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jpain.2014.04.003","article-title":"Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians","volume":"15","author":"Irvine","year":"2014","journal-title":"Journal of Pain"},{"issue":"12","key":"10.1016\/j.drugpo.2022.103856_bib0042","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s11606-019-05301-2","article-title":"Mortality after discontinuation of primary care-based chronic opioid therapy for pain: A retrospective cohort study","volume":"34","author":"James","year":"2019","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"10.1016\/j.drugpo.2022.103856_bib0043","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/0049124105283121","article-title":"Factorial survey methods for studying beliefs and judgments","volume":"34","author":"Jasso","year":"2006","journal-title":"Sociological Methods & Research"},{"issue":"2","key":"10.1016\/j.drugpo.2022.103856_bib0044","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/10826084.2017.1305415","article-title":"Prescription opioid misuse and public health approach in Australia","volume":"53","author":"Kovitwanichkanont","year":"2018","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.drugpo.2022.103856_bib0045","first-page":"e9","article-title":"Physician responses to enhanced prescription drug monitoring program profiles","author":"Leichtling","year":"2019","journal-title":"Pain Medicine"},{"issue":"6","key":"10.1016\/j.drugpo.2022.103856_bib0046","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/pm\/pnw251","article-title":"Clinicians\u2019 use of prescription drug monitoring programs in clinical practice and decision-making","volume":"18","author":"Leichtling","year":"2016","journal-title":"Pain Medicine"},{"issue":"6","key":"10.1016\/j.drugpo.2022.103856_bib0047","first-page":"207","article-title":"Investigation of simulated pharmacist decision making involving prescriptions with a high probability of causing patient harm","volume":"30","author":"Losey","year":"2014","journal-title":"The Journal of Pharmacy Technology : JPT : Official Publication of the Association of Pharmacy Technicians"},{"issue":"7","key":"10.1016\/j.drugpo.2022.103856_bib0048","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/pds.4003","article-title":"Characteristics of state prescription drug monitoring programs: A state-by-state survey","volume":"25","author":"Manasco","year":"2016","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.drugpo.2022.103856_bib0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2018.06.004","article-title":"Risks of fatal opioid overdose during the first year following nonfatal overdose","volume":"190","author":"Olfson","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2022.103856_bib0051","doi-asserted-by":"crossref","first-page":"M283","DOI":"10.1136\/bmj.m283","article-title":"Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: Observational evaluation","volume":"368","author":"Oliva","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.drugpo.2022.103856_bib0052","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugpo.2019.03.020","article-title":"Why aren't Australian pharmacists supplying naloxone? Findings from a qualitative study","volume":"69","author":"Olsen","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2022.103856_bib0053","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.japh.2019.09.016","article-title":"Prescription drug monitoring program use and utility by Washington State pharmacists: A mixed-methods study","volume":"60","author":"Pett","year":"2020","journal-title":"Journal of the American Pharmacists Association"},{"issue":"1","key":"10.1016\/j.drugpo.2022.103856_bib0054","doi-asserted-by":"crossref","first-page":"109090","DOI":"10.1016\/j.drugalcdep.2021.109090","article-title":"How prescription drug monitoring programs inform clinical decision-making: A mixed methods systematic review and meta-analysis","volume":"228","author":"Picco","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.drugpo.2022.103856_bib0055","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s11606-018-4374-1","article-title":"Physicians' perspectives regarding prescription drug monitoring program use within the department of veterans affairs: A multi-state qualitative study","volume":"33","author":"Radomski","year":"2018","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.drugpo.2022.103856_bib0056","series-title":"Measring social judgements: The factorial survey approach","author":"Rossi","year":"1982"},{"issue":"6","key":"10.1016\/j.drugpo.2022.103856_bib0057","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4088\/JCP.15m10386","article-title":"Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States","volume":"77","author":"Saha","year":"2016","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1016\/j.drugpo.2022.103856_bib0058","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants\u2014United States, 2015\u20132016","volume":"67","author":"Seth","year":"2018","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.drugpo.2022.103856_bib0059","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/pme.12700","article-title":"How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?","volume":"16","author":"Smith","year":"2015","journal-title":"Pain Medicine"},{"key":"10.1016\/j.drugpo.2022.103856_bib0060","doi-asserted-by":"crossref","first-page":"J760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: Retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.drugpo.2022.103856_bib0061","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/bjsw\/bch345","article-title":"Factorial surveys: Using vignettes to study professional judgement 1","volume":"36","author":"Taylor","year":"2005","journal-title":"The British Journal of Social Work"},{"issue":"1","key":"10.1016\/j.drugpo.2022.103856_bib0062","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.18549\/PharmPract.2020.1.1682","article-title":"Differences between pharmacists\u2019 perception of counseling and practice in the era of prescription drug misuse","volume":"18","author":"Thornton","year":"2020","journal-title":"Pharmacy Practice"},{"issue":"2","key":"10.1016\/j.drugpo.2022.103856_bib0063","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1197\/jamia.M1809","article-title":"Overriding of drug safety alerts in computerized physician order entry","volume":"13","author":"van der Sijs","year":"2006","journal-title":"Journal of the American Medical Informatics Association : JAMIA"},{"key":"10.1016\/j.drugpo.2022.103856_bib0065","unstructured":"Wheeler, B. (2019). AlgDesign: Algorithmic Experimental Design. R Package version 1.2.1. Accessed on 12 Sept 2022. Available from: https:\/\/CRAN.R-project.org\/package=AlgDesign."},{"issue":"1","key":"10.1016\/j.drugpo.2022.103856_bib0066","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1525\/jer.2006.1.1.9","article-title":"Cognitive interviewing as a tool for improving the informed consent process","volume":"1","author":"Willis","year":"2006","journal-title":"Journal of Empirical Research on Human Research Ethics"},{"issue":"12","key":"10.1016\/j.drugpo.2022.103856_bib0067","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jpain.2019.04.007","article-title":"Effectiveness of prescription monitoring programs in reducing opioid prescribing, dispensing, and use outcomes: A systematic review","volume":"20","author":"Wilson","year":"2019","journal-title":"The Journal of Pain"},{"issue":"1","key":"10.1016\/j.drugpo.2022.103856_bib0068","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pmn.2019.04.001","article-title":"Factors influencing judgments to consult prescription monitoring programs: A factorial survey experiment","volume":"21","author":"Witry","year":"2020","journal-title":"Pain Management Nursing: Official Journal of the American Society of Pain Management Nurses"},{"key":"10.1016\/j.drugpo.2022.103856_bib0049","unstructured":"Maven Marketing. (2019) List of pharmacies and chemists in Australia. Accessed on 12 Sept 2022 [Available from: Http:\/\/www.mavenmarketing.com.au\/list-of-pharmacies-in-australia\/."},{"key":"10.1016\/j.drugpo.2022.103856_bib0012","unstructured":"CoreList. (2020) List of pharmacies in Australia. Accessed on 12 Sept 2022 [Available from: Https:\/\/corelist.com.au\/pharmacies-in-australia\/."}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395922002729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395922002729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:36:51Z","timestamp":1777595811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395922002729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":68,"alternative-id":["S0955395922002729"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2022.103856","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How do patient, pharmacist and medication characteristics and prescription drug monitoring program alerts influence pharmacists' decisions to dispense opioids? A randomised controlled factorial experiment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2022.103856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103856"}}